PainChek General Discussion, page-197

First 197 Last

Share
Profile

Follow
Maysgr

1,671 Posts.

280

22/03/18

20:55

Post #: 31962604
Share

Originally posted by RNClarke ↑

FDA all depends on the classification of the product, either way it will be in the bag by end of this year for eventual commercialisation in the US.

It is clear the near term goal is to have PainChek succeed in Australia, and then later this year expand into Europe. The market in Australia is very significant and I won't be disappointed if the EU rollout is delayed by a quarter or two.

It sounds like we will see a few deals strung together over the next few months as on boarding continues with the new Android Application complete.

From 5:40 in the interview PD mentions:
"We are working with a large number of residential aged care groups now, large ones, medium ones, small ones and we're basically looking to implement it in their care management systems throughout Australia"

Another clinical specialist coming on board in April to assist with technical support is a sign of the inbound demand to come, no point hiring a full time position if there isn't significant work ahead.

Having the in home consumer version out by mid year will only increase uptake of the application and something shareholders should look forward too. Whilst PCK have been quiet, the register has only been tightening.

Expand

Perfect and refine the product in Australia first, then take the complete solution to the world.

I love PD's style, manage the business and not the share price.

No hype announcements trying to boost the share price, and that keeps the traders away.

Patience will be rewarded here.

PCK Price at posting: 6.2¢ Sentiment: Buy Disclosure: Held
10 Upvote

3 Great analysis

Reply

Top Stories

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

IDA

Indiana Resources to win US$90M from Tanzania following international lawsuit

BC8

Black Cat Syndicate one pour away from being rerated as producer

KGL

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

There are more pages in this discussion • 20,216 more messages in this thread...

First 197 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $63.79M

Open	High	Low	Value	Volume
4.0¢	4.0¢	3.9¢	$14.63K	374.0K

Buyers (Bids)

No.	Vol.	Price($)
1	933	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	1476010	4

View Market Depth

No.	Vol.	Price($)
1	933	0.039
3	506371	0.038
1	25000	0.037
1	114792	0.036
2	262933	0.035

Price($)	Vol.	No.
0.040	1476010	4
0.041	565454	2
0.042	362300	3
0.043	181299	2
0.044	475304	4

Last trade - 11.46am 29/07/2024 (20 minute delay)

PCK (ASX) Chart

PainChek General Discussion, page-197

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Indiana Resources to win US$90M from Tanzania following international lawsuit

Black Cat Syndicate one pour away from being rerated as producer

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PainChek General Discussion, page-197

Top Stories

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Indiana Resources to win US$90M from Tanzania following international lawsuit

Black Cat Syndicate one pour away from being rerated as producer

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News